Presentation TCT 2018 TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention? Presenter: John D. Puskas, Alfredo Trento, Craig Basman September 21, 2018
Presentation TCT 2018 TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice Presenter: John D. Puskas, Alfredo Trento, Choongki Kim September 21, 2018
Presentation TCT 2018 TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer September 21, 2018
Presentation TCT 2018 TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries Presenter: Allen Jeremias, Hernan Mejia-Renteria September 21, 2018
Presentation TCT 2018 TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino September 21, 2018
Presentation TCT 2018 Revascularization in Cardiogenic Shock: New Insights Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele September 21, 2018
Presentation TCT 2018 The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne September 21, 2018
Presentation ESC 2018 2018 ESC/EACTS Guidelines on Myocardial Revascularization Presenter: Franz-Josef Neumann August 30, 2018
Presentation ESC 2018 FUnctional Testing Underlying REvascularization The FUTURE trial Presenter: Gilles Rioufol August 26, 2018
Presentation The Structural Heart Disease Summit 2018 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization) Presenter: Torsten P. Vahl June 21, 2018
Presentation SCAI 2018 The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock Presenter: Andrew McNeice April 28, 2018
Presentation SCAI 2018 PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey Presenter: David E. Kandzari April 28, 2018
Presentation Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease April 23, 2018
Presentation Fellows 2018 Complete Revascularization of Complex Higher Risk (and Indicated) Patients: The Rationale Presenter: Gary S. Mintz, Jeffrey W. Moses April 14, 2018
Presentation CIT 2018 Best Practice for PCI: Lessons from SYNTAX II Presenter: Patrick W. Serruys March 23, 2018
Presentation ACC 2018 A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial) Presenter: Mehdi H. Shishehbor March 12, 2018
Presentation CHIP at ACC 2018 Opening Salvo: Where PCI Needs to Go in the Next 5-10 Years Presenter: Martin B. Leon March 09, 2018
Presentation JIM 2018 Left Ventricular Support During Complex Transradial Percutaneous Coronary Intervention for Complete Revascularization Presenter: Carlo Briguori February 23, 2018
Presentation Complete vs Culprit-Only Revascularization in STEMI With Multivessel Disease February 15, 2018